Norovirus and Rotavirus Vaccines for the World (NRVW) 2018

Norovirus and Rotavirus Vaccines for the World (NRVW) is organized by Meetings Management and will be held during Jun 04 - 06, 2018 at Lausanne University Hospital, Lausanne, Vaud, Switzerland.

Conference Description:
This Conference will offer a new forum for researchers to focus on an update of progress with rotavirus vaccines and developments in the research and ultimate implementation of norovirus vaccines.

The global health community is beginning to gain an understanding of the global burden of norovirus-associated disease, which appears to have significant burden in both developed- and developing-country populations. Of particular importance is the growing recognition of norovirus as a leading cause of gastroenteritis and diarrhea in countries where rotavirus vaccine has been introduced. While not as severe as rotavirus disease, the sheer number of norovirus infections not limited to early childhood makes norovirus a formidable global health problem. Multiple vaccine strategies, mostly relying on viruslike particle antigens, are under development and have demonstrated proof of efficacy in human challenge studies. Several are entering phase 2 clinical development. Norovirus vaccine development challenges include, but are not limited to: valency, induction of adequate immune responses in pediatric and elderly populations, and potential for vaccine-strain mismatch. Given current strategies and global health interest, the outlook for a norovirus vaccine is promising. Because a norovirus vaccine is expected to have a dual market in both developed and developing countries, there would likely be scale-up advantages for commercial development and global distribution. Combination with or expression by another enteric pathogen, such as rotavirus, could also enhance uptake of a norovirus vaccine.

Additional details will be posted as soon as they are available.